A new report from Lindt & Sprüngli suggests households using GLP-1 weight-loss medications are driving stronger growth in premium chocolate sales, even as some research shows overall food spending ...

The Swiss chocolate group raised prices by 19% last year and further increases are planned for 2026.

KILCHBERG, Switzerland — Chocolate sales are rising ​faster among U.S. users of GLP-1 weight-loss drugs than in ‌the rest of the population, Swiss chocolatier Lindt & Spruengli said on Tuesday, citing ...

Swiss chocolate manufacturer Lindt & Sprüngli on Tuesday announced an increase in full-year earnings for 2025 thanks to significant price increases for chocolate. The company's bottom line came in at ...

Lindt & Sprüngli posts strong 2025 results as profits, growth and cash flow surge. What this means for the chocolate industry – and what rivals can learn.

Earnings call Lindt & Sprüngli reported 12.4% organic sales growth in 2025, exceeding guidance, with EBIT margin rising to 16.4% and EPS up 8.5%. Despite cocoa-driven margin pressure and cautious near ...

Warren Ackerman of Barclays said he believed the cut to guidance was more focussed around consumer sentiment, given Lindt's ...

KILCHBERG, Switzerland, March 10 (Reuters) - Swiss chocolate maker Lindt & Spruengli said it was difficult to say how cocoa ...

By John Revill and Danny Callaghan KILCHBERG, Switzerland March 10 (Reuters) - Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, Swiss ...

The company, based in Kilchberg on Lake Zurich, had previously reported 2025 sales growth slightly ahead of expectations ...

Swiss stocks closed on a firm note on Tuesday, mirroring the positive trend across Europe, as a sharp drop in oil prices and U.S.

Swiss luxury chocolate maker Lindt & Spruengli has today cut its 2026 sales growth forecast, warning of a hit to consumer ...